genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
CRISPR Therapeutics
GEN Edge
StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
Alex Philippidis
-
October 19, 2023
0
Bioprocessing
Meeting on the Mesa: How to Bring Cell and Gene Therapies to Market
Jonathan D Grinstein, PhD
-
October 12, 2023
0
Drug Discovery
StockWatch: Investors Shrug as FDA Weighs First Gene-Edited Therapy
Alex Philippidis
-
June 12, 2023
437
Genome Editing
Prime-Edited Patient Blood Stem Cells Fully Engraft and Rescue Sickle Cell Mice
Jonathan D Grinstein, PhD
-
April 17, 2023
0
News
Insights
GEN Staff Writer
-
January 13, 2017
0
Scroll Up